Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2026-03-13 @ 12:25 PM
Study NCT ID:
NCT04992494
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2021-08-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment for Migraine and Mood (Team-M)
Sponsor:
NYU Langone Health
Organization:
Study Overview
Official Title:
Treatment for Migraine and Mood (Team-M): A Pilot Trial of a Mindfulness-based Training Program
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEAM-M
Brief Summary:
The researchers propose a two-arm pilot study of telephone and video delivered Mindfulness-based Cognitive Therapy (MBCT-T and MBCT-V) in people with migraine and depressive symptoms.
Detailed Description:
This study aims to set the stage for a future definitive large-scale Phase III trial in patients with migraine and depressive symptoms. This first phase is aimed at fidelity optimization of MBCT-T and MBCT-V in people with migraine (defined by the International Classification of Headache Disorders - 3) and depressive symptoms (defined by empirical cut-offs on the Patient Health Questionnaire - 9).
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R01AT011005 | NIH | None | https://reporter.nih.gov/quic… | View |